News

Inspired by the world's great Lego Masters, Arovella is taking a brick-by-brick approach to building its unique cancer ...
GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval, said the drugmaker this morning. The fast ...
They consider the FDA compared with the EMA in this context and question whether we are comparing them fairly. Cycle times for regulatory decisions are of great importance, especially in ...
Teva’s new chief executive Richard Francis highlighted the recent FDA approval of long-active schizophrenia therapy Uzedy (risperidone) as a key part of the company’s new “pivot to growth ...
AstraZeneca's oral therapy Truqap will soon be available for people with advanced breast cancer via the NHS in England – as long as testing is available to identify eligible patients. AKT ...
This webinar will also explore: The FDA’s stance on synthetic control arms being used in clinical trials How synthetic control arms reduce patient recruitment in clinical trials Managing the ...
As the incidence of cancer rises around the world, the demand for faster, more precise diagnoses is also on the rise. This demand will only intensify over time, as the worldwide incidence of ...
For the patient demanding access to the latest medicine or the healthcare professional desperate to be able to use a new advance in treatment, every extra day, week or month waiting counts.
AstraZeneca has enlisted the help of Lilly in the development of its new Alzheimer's candidate AZD3293. The drug is an oral beta secretase cleaving enzyme (BACE) inhibitor, which the companies ...
Delivery by drone is often talked about in the retail sector – to make delivery of consumer goods quicker and with greater convenience. However, Ben Hargreaves finds that the advantages for ...
Intellia Therapeutics has said it will reduce its headcount by 27% this year and shelve early-stage R&D programmes as it puts its resources behind two priority drug candidates. The specialist in ...
The White House has launched a national security investigation into the national security implications of importing pharmaceuticals, viewed as a precursor step on the way to tariffs threatened by ...